Heather Rowe | Senior Director, IR and Corporate Communications |
Aron Knickerbocker | CEO |
Dr. Helen Collins | Chief Medical Officer |
Marc Belsky | CFO |
Caroline Chen | RBC Capital Markets |
Chris Shibutani | Cowen |
Christopher Marai | Nomura |
Michael Schmidt | Leerink |
Good day ladies and gentlemen. And welcome to the Five Prime Therapeutics Fourth Quarter and Fiscal Year 2017 Earnings Call.
As a reminder, this conference may be recorded. I’d now like to introduce your host for today’s conference, Ms. Heather Rowe, Senior Director, Investor Relations, and Corporate Communications.